U.S. Bankruptcy Judge Christopher Lopez has dismissed Johnson & Johnson’s third effort to use bankruptcy to establish a multi-million ...

AnaptysBio (NASDAQ:ANAB – Get Free Report) and Silo Pharma (NASDAQ:SILO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses ...

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its ...

Anaptys has cash, cash equivalents and investments greater than $420 million as of December 31, 2024, and anticipates receipt of a $75 million commercial sales milestone payment from GSK in 2025 or ...

The insurance industry can be seemingly opaque, and Jason enjoys breaking down confusing terms and products to help others mak... Les Masterson is a deputy editor and insurance analyst at Forbes ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...

AltaGas Ltd (ALA.T) is expected to report $0.70 for 4Q. AnaptysBio Inc (ANAB) is expected to report $-1.62 for 4Q. Astria Therapeutics Inc (ATXS) is expected to report $-0.45 for 4Q. Biglari ...

ANAB remains risky despite new clinical data and partnerships; past successes haven't been replicated, and management's transparency issues raise concerns. The recent deal for Imsidolimab reflects ...

On the same day With Love, Meghan launched, Meghan Markle shared the first eight products from her brand, As Ever, developed in partnership with Netflix. Per a release from the brand ...

Discovering AnaptysBio: A Closer Look AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in ...